Randomised Double-blind Placebo-Controlled Multicentre Trial for the Effects of Yokukansan in Smokers with Depressive Tendencies.

Eur Cardiol · 2023 · PMC10316361 · PMID 37405335

Europe PMC DOI

hedged sentence

0.0730

closest p · 1.5× alpha

0.0730

boldest claim

The sentences

showed a trendp=0.073so close (0.05 < p ≤ 0.1)

The time × group interaction by repeated ANOVA on the improvement in depression-dejection was significant (p<0.019) and that in fatigue showed a trend (p=0.073).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.